Plan suggested for reducing health care costs
(HealthDay)—Health care costs can be reduced, with a nine-step plan suggested as a starting place, according to an article published in Medical Economics.
May 17, 2017
0
0
(HealthDay)—Health care costs can be reduced, with a nine-step plan suggested as a starting place, according to an article published in Medical Economics.
May 17, 2017
0
0
(HealthDay)—The prices of brand-name drugs used by many older Americans rose nearly 130 times faster than inflation last year, a new study reports.
Dec 14, 2016
0
0
An economist at The University of Texas at Austin will brief members of Congress on how insurers are using high out-of-pocket prescription drug costs to deter certain chronically ill patients from joining their plans in the ...
Nov 17, 2016
0
1
Hospitals, too, are getting slammed by sharp price increases in prescription drugs, and the industry is urging the next president and Congress to take up the issue.
Oct 11, 2016
0
0
Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients' treatment with a novel class of targeted therapies, according to a University of North ...
Oct 3, 2016
0
6
(HealthDay)—The proposed capping of copays will raise premiums and is likely to increase drug prices, according to a report from the National Center for Policy Analysis (NCPA).
Sep 29, 2016
0
0
(HealthDay)—New anticancer drugs, which increase costs considerably, are associated with large gains in life expectancy, according to research published in the September issue of Health Affairs.
Sep 13, 2016
0
1
Research has shown that surgery can provide important benefits for patients with epilepsy. Now a new study finds that it is also cost-effective.
Sep 7, 2016
0
0
Is the occurrence of a fragility fracture - where Medicare beneficiaries broke a hip, wrist or shoulder - a missed opportunity to reduce exposure to prescription drugs associated with fracture risk?
Aug 22, 2016
0
0
Although the recently FDA approved cholesterol-lowering drugs, PCSK9 inhibitors, could substantially reduce heart attacks, strokes, and cardiovascular deaths, they would not be cost-effective for use in patients with heterozygous ...
Aug 16, 2016
0
1